![]() |
市場調查報告書
商品編碼
1513768
全球裸金屬支架市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測Global Bare-metal Stents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球裸金屬支架市場需求預計將從2023年的38.1億美元達到近62.8億美元的市場規模,2024-2032年研究期間複合年成長率為5.69%。
裸金屬支架 (BMS) 是管狀網狀裝置,用於治療被診斷患有冠狀動脈疾病的個體狹窄或阻塞的冠狀動脈。這些支架由金屬製成,通常是不銹鋼或鈷鉻合金,並透過稱為血管成形術的微創手術插入動脈。 BMS 提供即時的結構支持,以保持動脈暢通,從而增強流向心臟的血液。然而,與藥物洗脫支架不同,BMS 不會釋放藥物來預防再狹窄(動脈重新變窄)。儘管如此,與藥物洗脫支架相比,由於其簡單性、成本效益以及降低極晚期支架血栓形成的風險,它們仍然被廣泛使用。
心血管疾病(如冠狀動脈疾病)發病率的增加推動了裸金屬支架市場的發展,這需要使用支架進行有效治療。支架技術和材料的進步提高了裸金屬支架的安全性和有效性,大大滿足了它們的需求。此外,微創外科手術數量的不斷增加以及某些患者群體對裸金屬支架的日益偏好也推動了市場的成長。老年人口的不斷增加,更容易患心血管疾病,進一步推動了市場的成長。政府對心血管疾病管理和改善新興經濟體醫療基礎設施的措施和資金為市場成長提供了有利的環境。
此外,人們對這些支架的好處及其在各種醫療保健環境中的可用性的認知不斷提高,推動了它們的採用。新型裸金屬支架設計的開發以及正在進行的研發活動也對市場產生了積極影響。然而,對藥物洗脫支架的日益青睞和再狹窄的風險可能會挑戰未來幾年的市場成長。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球裸金屬支架市場的各個細分市場進行了包容性評估。裸金屬支架產業的成長和趨勢為本研究提供了整體方法。
裸金屬支架市場報告的這一部分提供了國家和地區層面細分市場的詳細資料,從而幫助戰略家確定相應產品或服務的目標人群以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲裸金屬支架市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。裸金屬支架市場的主要參與者包括 Abbott Laboratories、Boston Scientific Corporation、Medtronic Plc、Terumo Corporation、Cook Medical、B. Braun Melsungen AG、Biotronik SE & Co. KG、Meril Life Sciences Pvt.。有限公司、Translumina GmbH、樂普醫療科技(北京)有限公司、其他。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Bare-metal Stents Market is presumed to reach the market size of nearly USD 6.28 Billion by 2032 from USD 3.81 Billion in 2023 with a CAGR of 5.69% under the study period 2024-2032.
Bare-metal stents (BMS) are tubular mesh devices used to manage narrowed or blocked coronary arteries in individuals diagnosed with coronary artery disease. These stents are made of metal, typically stainless steel or cobalt-chromium, and are inserted into the artery via a minimally invasive procedure called angioplasty. BMS provides immediate structural support to keep the artery open, enhancing blood flow to the heart. However, unlike drug-eluting stents, BMS does not release medication to prevent restenosis (re-narrowing of the artery). Despite this, they are still widely used due to their simplicity, cost-effectiveness, and reduced risk of very late stent thrombosis compared to drug-eluting stents.
The bare-metal stents market is propelled by the increasing incidence of cardiovascular diseases, like coronary artery disease, which necessitates using stents for effective treatment. Advances in stent technology and materials, enhancing the safety and efficacy of bare-metal stents, significantly contribute to their demand. Additionally, the growing number of minimally invasive surgical procedures and the increasing preference for bare-metal stents in certain patient populations propel market growth. The growing elderly population, who are more susceptible to cardiovascular conditions, further boosts the market growth. Government initiatives and funding for cardiovascular disease management and improving healthcare infrastructure in emerging economies provide a conducive environment for market growth.
Furthermore, increasing awareness about the benefits of these stents and their availability in various healthcare settings drives their adoption. The development of novel bare-metal stent designs and ongoing research and development activities also positively impact the market. However, the increasing preference for drug-eluting stents and the risk of restenosis may challenge market growth in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Bare-metal Stents. The growth and trends of Bare-metal Stents industry provide a holistic approach to this study.
This section of the Bare-metal Stents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Bare-metal Stents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Bare-metal Stents market include Abbott Laboratories, Boston Scientific Corporation, Medtronic Plc, Terumo Corporation, Cook Medical, B. Braun Melsungen AG, Biotronik SE & Co. KG, Meril Life Sciences Pvt. Ltd., Translumina GmbH, Lepu Medical Technology(Beijing) Co. Ltd., Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.